Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

NCT05628883 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma
Unresectable Melanoma
Acral Melanoma
Mucosal Melanoma
Cutaneous Melanoma
Ocular Melanoma
Uveal Melanoma
Iris Melanoma
Conjunctival Melanoma
Non-Cutaneous Melanoma

Interventions

BIOLOGICAL: TBio-4101
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]